Should a patient undergoing mitral valve replacement with tricuspid valve annuloplasty and coronary artery bypass grafting continue low‑dose aspirin (acetylsalicylic acid) up to the day of surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Should Ecosprin (Aspirin) Be Continued Until the Day of Surgery for Mitral Valve Replacement with TV Annuloplasty and CABG?

Yes, aspirin should be continued until the day of surgery for patients undergoing combined mitral valve replacement, tricuspid valve annuloplasty, and CABG. The presence of CABG in this combined procedure makes aspirin continuation the evidence-based standard of care.

Rationale for Continuation

The 2023 ACC/AHA guidelines explicitly recommend that patients undergoing CABG who are already taking aspirin preoperatively should continue it through the perioperative period 1. This is a Class I recommendation based on the principle that aspirin reduces postoperative mortality, myocardial infarction, stroke, renal failure, and bowel infarction when given within 48 hours after CABG 1.

Key Supporting Evidence

  • Aspirin continuation is associated with improved graft patency, particularly for saphenous vein grafts during the first postoperative year, which is critical for CABG outcomes 1.

  • The 2011 ACCF/AHA CABG guidelines state that aspirin (100-325 mg daily) should be administered preoperatively to CABG patients 1. If not started preoperatively, it must be initiated within 6 hours postoperatively 1.

  • The 2006 AHA/ACC secondary prevention guidelines recommend aspirin be started within 48 hours after CABG to reduce saphenous vein graft closure, with dosing regimens of 100-325 mg/day appearing efficacious 1.

Addressing the Bleeding Concern

While aspirin continuation does increase perioperative bleeding and transfusion requirements, this does not translate to increased surgical reoperation rates or mortality 1. The guidelines acknowledge this trade-off but prioritize the reduction in thrombotic complications:

  • Meta-analyses show aspirin continuation is associated with reduced MI risk but not increased death, despite modest increases in bleeding 1.

  • The benefit of preventing graft thrombosis and cardiovascular events outweighs the manageable risk of increased bleeding in the CABG context 1.

  • Recent research confirms that low-dose aspirin (≤100 mg/day) provides cardiovascular benefits without excessive bleeding compared to higher doses 2.

Dosing Recommendation

Use aspirin 75-100 mg (equivalent to standard ecosprin dosing) daily until the day of surgery 1. The 2023 ACC/AHA guidelines specify that 81 mg daily meets performance measure requirements, though the studied dose range is 100-325 mg 1.

Important Caveats

Exceptions to Continuation

Aspirin should be discontinued only if there are specific contraindications 1:

  • Documented aspirin allergy
  • Prohibitive bleeding risk (e.g., underlying bleeding dyscrasias, redo operations with extensive adhesions)
  • Patient refusal or inability to afford medication

Valve Surgery Considerations

The mitral valve replacement and tricuspid annuloplasty components do not change the recommendation when CABG is part of the procedure. The CABG component drives the aspirin management strategy because:

  • Graft patency is the primary concern 1
  • The thrombotic risk from coronary disease and new grafts supersedes valve-related considerations
  • Combined procedures follow CABG protocols for antiplatelet management 1

Postoperative Management

Resume or continue aspirin within 6 hours postoperatively if hemostasis is adequate 1. This should be continued indefinitely for secondary prevention 1.

Common Pitfalls to Avoid

  • Do not stop aspirin 3-5 days before elective CABG in patients already taking it—this outdated practice increases thrombotic risk without proven benefit in the modern era 1, 3.

  • Do not confuse CABG guidelines with non-cardiac surgery guidelines, where aspirin may be stopped for high-bleeding-risk procedures like neurosurgery 3. Cardiac surgery with CABG follows different protocols.

  • Do not delay restarting aspirin beyond 6 hours postoperatively unless there is active, uncontrolled bleeding 1.

Algorithm Summary

  1. Patient already on aspirin + scheduled for MVR/TV annuloplasty/CABG → Continue aspirin 75-100 mg daily until surgery 1

  2. Check for absolute contraindications (allergy, prohibitive bleeding risk) → If present, document medical reason for discontinuation 1

  3. Day of surgery → Continue aspirin through perioperative period 1

  4. Postoperatively → Resume/continue within 6 hours if hemostasis adequate 1

  5. Discharge → Continue aspirin indefinitely for secondary prevention 1

This approach is supported by the highest-quality guideline evidence and reflects contemporary cardiac surgical practice for combined procedures involving CABG 1.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

3
Guideline

Aspirin Management for High‑Bleeding Risk Surgical Procedures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

After a four‑graft coronary artery bypass graft (CABG) surgery, how long may aspirin be withheld before it should be resumed?
Should low‑dose aspirin (81 mg) be taken during pregnancy, and if so, when is it appropriate?
What are the pre‑operative recommendations for discontinuing low‑dose aspirin in a patient with three‑vessel coronary artery disease undergoing elective surgery?
What is the recommended management of aspirin therapy for a patient with uncontrolled epilepsy and a cardiovascular condition undergoing Coronary Artery Bypass Grafting (CABG) surgery?
Should low‑dose aspirin (acetylsalicylic acid) be continued in a patient with a 70% lesion of the left anterior descending (LAD) artery until the day of surgery?
Is olanzapine an appropriate first‑line treatment for a patient with mild‑to‑moderate mania who also requires sedation to aid sleep?
Is cefpirome considered a high‑potency antibiotic?
Is a single dose of clonazepam 0.5 mg appropriate for short‑term management of anxiety and restlessness that occur when I am alone, in a patient who recently reduced baclofen from 40 mg to 10 mg daily and stopped a two‑month guaifenesin course, without seizures, hallucinations, or altered consciousness?
What is the recommended management for allergic conjunctivitis?
How do I determine whether to order a CT (computed tomography) versus an MRI (magnetic resonance imaging)?
In a 73‑year‑old patient with coronary artery disease status post triple coronary artery bypass grafting (left internal mammary artery to left anterior descending artery, saphenous‑vein grafts to posterior descending artery and diagonal branch 1) who is asymptomatic and has no bleeding, should low‑dose aspirin 81 mg be continued indefinitely according to guidelines?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question